Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes.
about
DPP4 inhibition prevents AKI.The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin.Age modifies the risk factor profiles for acute kidney injury among recently diagnosed type 2 diabetic patients: a population-based study.Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute OutcomesIs there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review
P2860
Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Dipeptidyl peptidase 4 inhibit ...... ury in patients with diabetes.
@en
type
label
Dipeptidyl peptidase 4 inhibit ...... ury in patients with diabetes.
@en
prefLabel
Dipeptidyl peptidase 4 inhibit ...... ury in patients with diabetes.
@en
P2093
P2860
P356
P1433
P1476
Dipeptidyl peptidase 4 inhibit ...... ury in patients with diabetes.
@en
P2093
Chia-Ter Chao
Hon-Yen Wu
Kuan-Yu Hung
Kuo-Liong Chien
P2860
P304
53028-53040
P356
10.18632/ONCOTARGET.18081
P407
P577
2017-05-23T00:00:00Z